MRSA screening test

The Practical Answer
The MicroPhage MRSA screening test identifies methicillin-resistant S. aureus (MRSA) when you need rapid results in a simple-to-use, cost sensible format.

MicroPhage’s bacteriophage amplification technology will provide the performance of molecular results at a price that is more in line with chromagenic culture media. The easy-to-use platform allows for simple, unbatched test starts and rapid batched or unbatched results, perfect for an early morning delivery of hospital-wide results when Infection Control can best use them. The MicroPhage MRSA screening test is ideal for institutions concerned with screening for MRSA in their patients that may not have the capacity for molecular or traditional microbiology.

MicroPhage delivers a high-value diagnostic in an easy-to-use platform:

Simple to perform: 3 minutes hands-on time; visual interpretation; unbatched
Rapid time to results: 12 hours; stable results in up to 24 hours, start-to-finish*
High specificity
High sensitivity

1 Farr and Jarvis. Infect. Control Hosp. Epidemiol. (23): 65-68.
* This test is not cleared by the FDA and not yet available for sale in the U.S. market.